VIPoma surgery: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
{{CMG}}{{AE}}{{MSI}}{{PSD}}
{{CMG}}{{AE}}{{MSI}}{{PSD}}
==Overview==
==Overview==
Surgery is the mainstay of treatment for VIPoma.<ref name=surgery>Pancreatic Neuroendocrine Tumors (Islet Cell Tumors). National Cancer Institute. http://www.cancer.gov/types/pancreatic/hp/pnet-treatment-pdq#section/_78. Accessed on October 21, 2015.</ref>
Surgery is the mainstay of treatment for VIPoma.<ref name="surgery">Pancreatic Neuroendocrine Tumors (Islet Cell Tumors). National Cancer Institute. http://www.cancer.gov/types/pancreatic/hp/pnet-treatment-pdq#section/_78. Accessed on October 21, 2015.</ref>
==Surgery==
==Surgery==
*Surgery is the mainstay of treatment for VIPoma. The feasibility of surgery depends on the stage of VIPoma at diagnosis.<ref name=surgery>Pancreatic Neuroendocrine Tumors (Islet Cell Tumors). National Cancer Institute. http://www.cancer.gov/types/pancreatic/hp/pnet-treatment-pdq#section/_78. Accessed on October 21, 2015.</ref>
*Surgery is the mainstay of treatment for VIPoma. The feasibility of surgery depends on the stage of VIPoma at diagnosis.<ref name="surgery">Pancreatic Neuroendocrine Tumors (Islet Cell Tumors). National Cancer Institute. http://www.cancer.gov/types/pancreatic/hp/pnet-treatment-pdq#section/_78. Accessed on October 21, 2015.</ref>
*If the tumor cannot be removed completely, surgical debulking may have palliative benefit.<ref name=sp>Vinik A. Vasoactive Intestinal Peptide Tumor (VIPoma) [Updated 2013 Nov 28]. In: De Groot LJ, Beck-Peccoz P, Chrousos G, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: http://www.ncbi.nlm.nih.gov/books/NBK278960/</ref>
*If the tumor cannot be removed completely, surgical debulking may have palliative effect for control of hormonal symptoms.<ref name="sp">Vinik A. Vasoactive Intestinal Peptide Tumor (VIPoma) [Updated 2013 Nov 28]. In: De Groot LJ, Beck-Peccoz P, Chrousos G, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: http://www.ncbi.nlm.nih.gov/books/NBK278960/</ref>
*In nonresectable liver metastases, Hepatic TACE (transarterial chemoembolization) is  emerging as a new non-emergency therapeutic modality  highly successful for control of VIP-related symptoms.<ref name="pmid4981295">{{cite journal| author=Blaise A, Girardet JL| title=[Study of the magnetic properties of siderophilin]. | journal=C R Acad Sci Hebd Seances Acad Sci D | year= 1969 | volume= 269 | issue= 10 | pages= 966-8 | pmid=4981295 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4981295  }}</ref>
<gallery>Image:Intra_operative.jpg| Intraoperative aspect of liver lesions (arrows).<ref name="APODACA-TORREZTRIVIÑO2014">{{cite journal|last1=APODACA-TORREZ|first1=Franz R.|last2=TRIVIÑO|first2=Marcello|last3=LOBO|first3=Edson José|last4=GOLDENBERG|first4=Alberto|last5=TRIVIÑO|first5=Tarcísio|title=Extra-pancreatic vipoma|journal=ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)|volume=27|issue=3|year=2014|pages=222–223|issn=0102-6720|doi=10.1590/S0102-67202014000300015}}</ref>
<gallery>Image:Intra_operative.jpg| Intraoperative aspect of liver lesions (arrows).<ref name="APODACA-TORREZTRIVIÑO2014">{{cite journal|last1=APODACA-TORREZ|first1=Franz R.|last2=TRIVIÑO|first2=Marcello|last3=LOBO|first3=Edson José|last4=GOLDENBERG|first4=Alberto|last5=TRIVIÑO|first5=Tarcísio|title=Extra-pancreatic vipoma|journal=ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)|volume=27|issue=3|year=2014|pages=222–223|issn=0102-6720|doi=10.1590/S0102-67202014000300015}}</ref>



Revision as of 16:41, 9 January 2018

VIPoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating VIPoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

VIPoma surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of VIPoma surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on VIPoma surgery

CDC on VIPoma surgery

VIPoma surgery in the news

Blogs on VIPoma surgery

Directions to Hospitals Treating VIPoma

Risk calculators and risk factors for VIPoma surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Madhu Sigdel M.B.B.S.[2]Parminder Dhingra, M.D. [3]

Overview

Surgery is the mainstay of treatment for VIPoma.[1]

Surgery

  • Surgery is the mainstay of treatment for VIPoma. The feasibility of surgery depends on the stage of VIPoma at diagnosis.[1]
  • If the tumor cannot be removed completely, surgical debulking may have palliative effect for control of hormonal symptoms.[2]
  • In nonresectable liver metastases, Hepatic TACE (transarterial chemoembolization) is emerging as a new non-emergency therapeutic modality highly successful for control of VIP-related symptoms.[3]

References

  1. 1.0 1.1 Pancreatic Neuroendocrine Tumors (Islet Cell Tumors). National Cancer Institute. http://www.cancer.gov/types/pancreatic/hp/pnet-treatment-pdq#section/_78. Accessed on October 21, 2015.
  2. Vinik A. Vasoactive Intestinal Peptide Tumor (VIPoma) [Updated 2013 Nov 28]. In: De Groot LJ, Beck-Peccoz P, Chrousos G, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: http://www.ncbi.nlm.nih.gov/books/NBK278960/
  3. Blaise A, Girardet JL (1969). "[Study of the magnetic properties of siderophilin]". C R Acad Sci Hebd Seances Acad Sci D. 269 (10): 966–8. PMID 4981295.
  4. APODACA-TORREZ, Franz R.; TRIVIÑO, Marcello; LOBO, Edson José; GOLDENBERG, Alberto; TRIVIÑO, Tarcísio (2014). "Extra-pancreatic vipoma". ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo). 27 (3): 222–223. doi:10.1590/S0102-67202014000300015. ISSN 0102-6720.


Template:WikiDoc Sources